Company intelligence / Profile preview

SafeMedWaste

South Carolina, United Statessafemedwaste.com ↗

Ownership: Private
Development stage: Commercial

Overview

SafeMedWaste has demonstrated, through independent DEA-accredited laboratory testing, that its patented chemical digestion system provides complete molecular destruction of controlled substances—including opioids—within minutes to hours. The byproduct is pH-neutral, non-hazardous, and safe for landfill disposal. A pilot clinical trial is underway to evaluate at-home opioid disposal efficacy among post-surgical patients.

Modalities: DeviceChemical digestion technology (for drug destruction; not a therapeutic modality but a proprietary chemical process for waste management)
Industry: Consumable Medical Devices

Partnerships

DEA-accredited laboratories (for validation/testing)Clinical research partners conducting trials in outpatient surgery clinics

Beyond the preview

Go deeper on SafeMedWaste.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SafeMedWaste.

Explore the full profile